Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/13/1998 | US5821351 Chimeric human globin gene |
10/13/1998 | US5821350 Aspergillus niger beta-galactosidase gene |
10/13/1998 | US5821341 Antibodies to sICAM-1 |
10/13/1998 | US5821337 Immunoglobulin variants |
10/13/1998 | US5821336 Polypeptide having specified amino acid sequence or fragment thereof |
10/13/1998 | US5821335 Biosynthetic gene murg from streptococcus pneumoniae |
10/13/1998 | US5821333 Method for making heteromultimeric polypeptides |
10/13/1998 | US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response |
10/13/1998 | US5821328 Genetic markers for breast, ovarian, and prostatic cancer |
10/13/1998 | US5821238 Administering to patient to impair tumor growth |
10/13/1998 | US5821235 Gene therapy using the intestine |
10/13/1998 | US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene |
10/13/1998 | US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide |
10/13/1998 | US5821224 Purified beta-defensin with consensus sequence having net positive charge that lacks three consecutive basic amino acids at the carboxyl terminus; polyclonal and monoclonal antibodies and drugs |
10/13/1998 | US5821223 Plasminogen-like growth factor |
10/13/1998 | US5821219 Opioid antagonists and methods of their use |
10/13/1998 | US5821125 Monoclonal antibody specific for novel PKA binding proteins |
10/13/1998 | US5821124 Hybridoma cell lines and antibodies that bind noggin |
10/13/1998 | US5821123 Modified antibody variable domains |
10/13/1998 | US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof |
10/13/1998 | US5821119 Shuttle vectors for Escherichia coli and cyanobateria |
10/13/1998 | US5821118 Genes for the subunits of human farnesyl-protein transferase |
10/13/1998 | US5821117 Porcine cell comprising alpa-1,3 galactosyl transferase |
10/13/1998 | US5821107 Contacting nematode cyclophilin-like protein with test compound, measuring effects on peptidyl-prolyl cis-trans isomerase activity |
10/13/1998 | US5821106 Salmonase prepared from a korean viper |
10/13/1998 | US5821105 Tissue plasminogen activator having zymognic or fibrin specific properties |
10/13/1998 | US5821104 Tripeptidyl aminopeptidase |
10/13/1998 | US5821103 Deoxyribonuclease |
10/13/1998 | US5821102 Recombinant production of lipase for use in alkaline detergents |
10/13/1998 | US5821098 Isolated nucleic acid encoding protein having specified amino acid sequence |
10/13/1998 | US5821094 S-locus receptor kinase gene in a self-incompatible brassica napus line |
10/13/1998 | US5821093 Recombinant cells that highly express chromosomally-integrated heterologous genes |
10/13/1998 | US5821092 Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase |
10/13/1998 | US5821091 Method of identifying activated T-cells |
10/13/1998 | US5821090 Riboflavin-biosynthesis in fungi |
10/13/1998 | US5821089 Contacting prokaryotic or eukaryotic cell with growth medium containing trans-4-hydroxyproline or 3-hydroxyproline to incorporate analog into polypeptide produced by cell |
10/13/1998 | US5821088 Use of gram-positive bacteria to express recombinant proteins |
10/13/1998 | US5821086 Polynucleotide fragment encoding polypeptide |
10/13/1998 | US5821083 A dna encoding an enzyme of xenopus laevis origin; expressed in e. coli host and recovering enzyme protein |
10/13/1998 | US5821082 Anti-proliferation domain of a human Bcl-2 and DNA encoding the same |
10/13/1998 | US5821081 Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides |
10/13/1998 | US5821079 Vectors for the expression and secretion of hirudin by transformed yeasts |
10/13/1998 | US5821078 Nucleic acid encoding interferon-α/β binding protein |
10/13/1998 | US5821077 Process for activating gene expression in bacteria |
10/13/1998 | US5821076 Identification of essential survival genes |
10/13/1998 | US5821075 Nucleotide sequences for novel protein tyrosine phosphatases |
10/13/1998 | US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections |
10/13/1998 | US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same |
10/13/1998 | US5821067 Mammalian methadone-specific opioid receptor and uses in binding assays |
10/13/1998 | US5821059 Mycoplasma expression system |
10/13/1998 | US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte |
10/13/1998 | US5821052 Control of the synthesis of proteins by anitisense RNA-tRNA complex |
10/13/1998 | US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus |
10/13/1998 | US5821050 Drug screening assay for antiviral activity against papillomavirus |
10/13/1998 | US5821049 Contacting compound with test cell transfected with recombinant nucleic acid from dna or rna virus encoding transforming protein, scoring cell growth based on selected transformation characteristic |
10/13/1998 | US5821048 Methods, kits, and compositions for diagnosing papillomavirus infection |
10/13/1998 | US5821047 Fusing a gene encoding a protein of interest to the carboxy terminal domain of the gene iii coat protein of the filamentous phage m13; mutation to form library; expressed in low quantity on surface of phagemid particle |
10/13/1998 | US5821046 RNA oligonucleotides that bind HIV tat protein |
10/13/1998 | US5821038 Yeast with modified permeability |
10/13/1998 | US5820871 Influenza virus, due to its genetic variability, stimulates immunity without developing a tolerance |
10/13/1998 | US5820869 Gene comprising dna sequence encoding the envelope protein |
10/13/1998 | US5820868 Recombinant protein production in bovine adenovirus expression vector system |
10/13/1998 | US5820866 Product and process for T cell regulation |
10/13/1998 | US5820864 Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease |
10/13/1998 | US5820863 A non-naturally occuring non-rodent zona pellucida polypeptide which is the expression product of dna encoding a mammalian zona pellucia polypeptide having immunological cross-reactivity with zona pellucida protein encoded by dna |
10/13/1998 | US5820861 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
10/13/1998 | US5820860 Comprises a capsular polysaccharide that elicits antibodies to group b streptococcus conjugated to a c protein alpha antigen or beta antigen of said group b streptococcus |
10/13/1998 | US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting |
10/13/1998 | US5820858 Methods and compositions for inhibiting CD14 mediated cell activation |
10/13/1998 | US5820857 Recombinant enzyme for fragmenting N-acetylheparosan |
10/13/1998 | US5820847 Administering a diagnostic agent complexed with a targeting ligand of folates or receptor-binding derivatives; for transporting exogenous molecules into cells with folate receptors; drug delivery |
10/13/1998 | CA1340082C Bovine interleukin-10c |
10/13/1998 | CA1340081C Class of low calorie protein sweeteners |
10/10/1998 | CA2233524A1 Novel compounds |
10/10/1998 | CA2228719A1 Live attenuated bacteria of the species actinobacillus pleuropneumoniae |
10/09/1998 | CA2234472A1 Vaccines |
10/08/1998 | WO1998044350A1 Detection of molecular interactions by reporter subunit complementation |
10/08/1998 | WO1998044161A1 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr) |
10/08/1998 | WO1998044160A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | WO1998044159A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | WO1998044158A1 Simultaneous collection of dna and non-nucleic analytes from oral fluids |
10/08/1998 | WO1998044156A1 Nucleic acid ladders |
10/08/1998 | WO1998044155A1 Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
10/08/1998 | WO1998044154A1 Inhibiting protein synthesis to improve genetic analysis |
10/08/1998 | WO1998044152A1 Method of nucleic acid sequencing |
10/08/1998 | WO1998044151A1 Method of nucleic acid amplification |
10/08/1998 | WO1998044149A1 Detection of dna damaging agents |
10/08/1998 | WO1998044147A1 Screening methods in eucaryotic cells |
10/08/1998 | WO1998044145A1 A process for synthesizing oligosaccharides |
10/08/1998 | WO1998044143A1 Polymer-modified viruses |
10/08/1998 | WO1998044141A2 Insect expression vectors |
10/08/1998 | WO1998044140A1 Glyphosate resistant maize lines |
10/08/1998 | WO1998044139A1 Improved sar plant transformation process |
10/08/1998 | WO1998044138A1 Improvements relating to the specificity of gene expression |
10/08/1998 | WO1998044137A2 Plant pest control |
10/08/1998 | WO1998044136A1 Genetic method for producing virus resistant organisms |
10/08/1998 | WO1998044135A2 Method for screening antimycotically active substances |
10/08/1998 | WO1998044134A2 Bacterial plasmids |
10/08/1998 | WO1998044133A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
10/08/1998 | WO1998044132A1 VIRAL VECTORS HAVING CHIMERIC ENVELOPE PROTEINS CONTAINING THE IgG-BINDING DOMAIN OF PROTEIN A |